EMA SUGGEST TEST TO BOOST THE NUMBER OF ELDERLY SUBJECTS IN CLINICAL TRIALS
January 1st, 2016
THE USE of simple physical tests to assess frailty in older clinical trial subjects can be an effective way to measure the likelihood of a patient having a positive response to medicine, a European Medicines Agency (EMA) assessment has concluded. A discussion paper ‘Points to consider on frailty: Evaluation instruments for baseline characterisation of clinical trial populations’ highlights the potential of the ‘Short Physical Performance Battery’ (SPPB) test. It assesses lower-extremity function through testing standing balance, walking speed, and ability ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.